All lobbying filings

MCALLISTER & QUINN, LLC

Lobbying for AURAVAX THERAPEUTICS · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Texas · Senate · $50,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 1

S 2572
Department of Defense Appropriations Act, 2026

Lobbying activity 3

Budget/Appropriations

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Defense

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Health Issues

Department of Defense Appropriations S. 2572 - Department of Defense Appropriations Act, 2026 - Provisions related to Auravaxs appropriations requests.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.